UFP Technologies (UFPT) Q2 2025 earnings summary

Executive summary

• Net sales for Q2 2025 rose 37.2% to $151.2 million, with 5% organic growth and strong performance in medical and robotic-assisted surgery segments; MedTech sales up 46%, Advanced Components down 20%.

• Adjusted operating income increased 35% and adjusted EPS grew 27% to $2.50; net income for Q2 was $17.2 million ($2.21 EPS), up from $13.6 million ($1.75 EPS) year-over-year.

• Growth was driven by multi-year contracts, expansion in patient services, interventional, surgical, and wound care markets, and contributions from 2024 and 2025 acquisitions.

• Largest two customers accounted for 27.4% and 20.3% of Q2 net sales.

• Expansion underway in the Dominican Republic to support growth in safe patient handling and robotic-assisted surgery markets.

Financial highlights

• Q2 2025 gross margin was 28.8%, down from 30.0% year-over-year, impacted by higher costs and labor inefficiencies at AJR; adjusted operating margin at 18%.

• Q2 net income was $17.2 million; adjusted net income reached $19.4 million; adjusted EBITDA for Q2 grew 33.2% to $31.8 million.

• Generated $25.3 million in cash from operations in Q2 and $39.1 million for the first half of 2025.

• Capital expenditures totaled $2.9 million in Q2; net cash used in investing activities for the first half was $8.5 million.

• Outstanding debt at June 30, 2025 was $163.6 million, with a leverage ratio well below 1.5x and a weighted average interest rate of 5.7%.

Outlook and guidance

• Q3 expected to be the low point for labor inefficiency, with a $7 million revenue and $2.5 million operating income impact; improvement anticipated in Q4.

• Margin rebound anticipated in Q4 as labor issues subside; tariffs expected to have minimal margin impact.

• Ongoing focus on strategic acquisitions, operational efficiency, and cost reduction.

• No material impact expected from the "One Big Beautiful Bill Act" on income tax expense.

• Strong pipeline of internal and acquisition-driven growth opportunities.